{
    "Question_1": {
        "Context": "The study investigated the uptake of PLGA nanoparticles by murine macrophage RAW264.7 cells using fluorescence microscopy. The experiment involved assessing the internalization of nanoparticles of different sizes by the cells.",
        "Question": "What was the primary method used to assess the uptake of PLGA nanoparticles by RAW264.7 cells?",
        "A": "Flow cytometry",
        "B": "Positron emission tomography",
        "C": "Fluorescence microscopy",
        "D": "Magnetic resonance imaging",
        "Answer": "C",
        "Source": "We assessed the variations in the uptake of APC-labelled PLGA-NH2 nanoparticles by RAW264.7 cells based on size following a 24-h incubation period (Fig. 2)."
    },
    "Question_2": {
        "Context": "The study focused on the biodistribution of 89Zr-PLGA-NH2 nanoparticles in mice following different routes of administration. The experiment involved monitoring the distribution of nanoparticles in major organs over a specified period.",
        "Question": "Which organ exhibited the highest initial distribution of nanoparticles after intravenous administration in mice?",
        "A": "Lungs",
        "B": "Liver",
        "C": "Spleen",
        "D": "Kidneys",
        "Answer": "B",
        "Source": "In mice that were intravenously administered nanoparticles, we observed substantial distribution of the nanoparticles in the liver (28.3 \u00b1 13.61%ID/g), lungs (14.76 \u00b1 0.8%ID/g), and spleen (5.96 \u00b1 2.04%ID/g)."
    },
    "Question_3": {
        "Context": "The study examined the influence of nanoparticle size on cellular uptake in vitro using RAW264.7 cells. The experiment involved assessing the uptake of fluorescently labelled PLGA-NH2 nanoparticles of different sizes by the cells.",
        "Question": "Which size of nanoparticles showed the highest uptake by RAW264.7 cells after 24 hours of incubation?",
        "A": "300 nm",
        "B": "600 nm",
        "C": "900 nm",
        "D": "Size did not affect uptake",
        "Answer": "A",
        "Source": "After 24 h, RAW264.7 cells exhibited a preference for 300- and 900-nm nanoparticles, whereas the uptake of 600-nm nanoparticles was lower than that of the other nanoparticles."
    },
    "Question_4": {
        "Context": "The study investigated the biodistribution of 89Zr-PLGA-NH2 nanoparticles in major tissues following intramuscular and subcutaneous injections in mice. The experiment involved tracking the distribution of nanoparticles in different tissues after administration via these routes.",
        "Question": "Which route of administration resulted in the least distribution of nanoparticles in the lungs in mice?",
        "A": "Intramuscular",
        "B": "Subcutaneous",
        "C": "Intravenous",
        "D": "Intranasal",
        "Answer": "A",
        "Source": "In the case of intramuscular and subcutaneous injections, most nanoparticles remained around the injection site throughout the tracking period, with only a small quantity being eliminated by the kidneys."
    },
    "Question_5": {
        "Context": "The study examined the biodistribution of 89Zr-PLGA-NH2 nanoparticles in mice following intravenous and intranasal administrations. The experiment involved monitoring the distribution of nanoparticles in major organs over a specified period.",
        "Question": "Which route of administration resulted in the highest pulmonary uptake of nanoparticles in mice?",
        "A": "Intravenous",
        "B": "Intranasal",
        "C": "Subcutaneous",
        "D": "Intramuscular",
        "Answer": "B",
        "Source": "In our in vivo experiments, radiolabelled nanoparticles exhibited significantly higher pulmonary uptake when administered intranasally rather than intravenously."
    },
    "Question_6": {
        "Context": "The study focused on the uptake of PLGA-NH2 nanoparticles by lung immune cells in mice following intranasal administration. The experiment involved quantifying nanoparticle uptake by different immune cell subsets in the lungs at various time points.",
        "Question": "Which type of immune cells consistently exhibited a trend toward increased nanoparticle uptake compared to lymphoid immune cells?",
        "A": "Alveolar macrophages",
        "B": "Dendritic cells",
        "C": "Monocytes",
        "D": "T cells",
        "Answer": "A",
        "Source": "Across all observed time points, immune cell subsets, including alveolar macrophages, dendritic cells (DCs), monocytes, and neutrophils, consistently exhibited a trend toward increased nanoparticle uptake compared to lymphoid immune cells."
    },
    "Question_7": {
        "Context": "The study investigated the biodistribution of 89Zr-PLGA-NH2 nanoparticles in major tissues following intravenous and intranasal administrations in mice. The experiment involved tracking the distribution of nanoparticles in different organs over a specified period.",
        "Question": "Which organ exhibited the most substantial distribution of nanoparticles after intranasal administration in mice?",
        "A": "Lungs",
        "B": "Liver",
        "C": "Spleen",
        "D": "Kidneys",
        "Answer": "A",
        "Source": "In the case of nasal administration, a persistent distribution of nanoparticles in the lungs was observed throughout the study period."
    },
    "Question_8": {
        "Context": "The study examined the uptake of PLGA-NH2 nanoparticles by lung immune cells in mice following intranasal administration. The experiment involved quantifying nanoparticle uptake by different immune cell subsets in the lungs at various time points.",
        "Question": "Which immune cell subset consistently demonstrated a relatively higher tendency for nanoparticle uptake than lymphoid immune cells?",
        "A": "Alveolar macrophages",
        "B": "Dendritic cells",
        "C": "Monocytes",
        "D": "T cells",
        "Answer": "B",
        "Source": "Myeloid immune cells consistently demonstrated a relatively higher tendency for nanoparticle uptake than lymphoid immune cells, irrespective of the time after nanoparticle administration."
    },
    "Question_9": {
        "Context": "The study focused on the biodistribution of 89Zr-PLGA-NH2 nanoparticles in major tissues following intravenous and intranasal administrations in mice. The experiment involved monitoring the distribution of nanoparticles in different organs over a specified period.",
        "Question": "Which route of administration resulted in the least distribution of nanoparticles in the liver in mice?",
        "A": "Intravenous",
        "B": "Intranasal",
        "C": "Subcutaneous",
        "D": "Intramuscular",
        "Answer": "B",
        "Source": "Furthermore, nanoparticle accumulation in the liver and spleen of mice in the nasal administration group was almost negligible compared with that among mice in the intravenous administration group."
    },
    "Question_10": {
        "Context": "The study investigated the uptake of PLGA-NH2 nanoparticles by lung immune cells in mice following intranasal administration. The experiment involved quantifying nanoparticle uptake by different immune cell subsets in the lungs at various time points.",
        "Question": "Which immune cell subset exhibited a sharp decline in nanoparticle uptake at 12 hours post-administration?",
        "A": "Alveolar macrophages",
        "B": "Dendritic cells",
        "C": "Monocytes",
        "D": "T cells",
        "Answer": "B",
        "Source": "DCs exhibited a sharp decline in nanoparticle uptake at 12 h, with the lowest uptake level among myeloid immune cells at 48 h."
    }
}